Side-By-Side Evaluation of Three Commercial ELISAs for the Quantification of SARS-CoV-2 IgG AntibodiesSARS-CoV-2 IgG 항체의 정량화를 위한 3가지 상용 ELISA의 병행 평가Article Published on 2022-03-112022-09-12 Journal: Viruses [Category] MERS, SARS, 진단, [키워드] anti-SARS-CoV-2 antibodies antibody unit BAU calibrated comparability COVID-19 creating ELISA ELISA kit examined Germany highlight IgG IgG ELISA Immunoglobulin International Interpretation Kiel Lubeck neutralization tests quantification Quantitative SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 IgG antibodies serological test serum sample tested the WHO Topic vaccinated individual virus neutralization test WHO [DOI] 10.3390/v14030577 PMC 바로가기 [Article Type] Article
Persistence of humoral response upon SARS-CoV-2 infectionSARS-CoV-2 감염 시 체액 반응 지속Article Published on 2022-03-012022-09-11 Journal: Reviews in Medical Virology [Category] MERS, SARS, 변종, 진단, 치료기술, [키워드] adaptive Adults antibody Antibody Response comparability COVID-19 detectability Economy eight global health Health humoral Humoral response IgA IgG IgM immune responses Immunity Immunoglobulin Immunoglobulin G immunoglobulins in some majority memory B mucosal Neutralizing antibodies neutralizing antibody neutralizing capacity pandemic PCR-confirmed persistence progression Re-infection reported SARS-CoV-2 SARS-COV-2 infection sensitive assay sensitive assays seropositive individual seropositive individuals T cell T cells tested virus variants while [DOI] 10.1002/rmv.2272 PMC 바로가기 [Article Type] Article
How to accelerate the supply of vaccines to all populations worldwide? Part II: Initial industry lessons learned and detailed technical reflections leveraging the COVID-19 situation전 세계 모든 인구에 대한 백신 공급을 가속화하는 방법은 무엇입니까? 2부: COVID-19 상황을 활용한 초기 업계 교훈 및 상세한 기술적 반성Review Published on 2022-02-232022-09-11 Journal: Vaccine [Category] COVID19(2023년), SARS, 변종, 신약개발, [키워드] accelerate approaches benefit changes comparability COVID-19 COVID-19 pandemic COVID-19 situation Digital disease Diseases distribution feasible genetically modified organisms harmonization Health heterogeneity majority market offer organism pace Part pathogen Pathogens Population populations public health public health threat Quality control Regulatory Regulatory convergence Reliance Risk-based Science Science-based stability Streamline the vaccine Treatment vaccination Vaccine Vaccines variants while [DOI] 10.1016/j.vaccine.2021.12.038 PMC 바로가기 [Article Type] Review
How to accelerate the supply of vaccines to all populations worldwide? Part I: Initial industry lessons learned and practical overarching proposals leveraging the COVID-19 situation전 세계 모든 인구에 대한 백신 공급을 가속화하는 방법은 무엇입니까? 1부: COVID-19 상황을 활용한 초기 업계 교훈 및 실질적이고 포괄적인 제안Review Published on 2022-02-232022-09-11 Journal: Vaccine [Category] COVID19(2023년), SARS, 변종, [키워드] accelerate addressed approaches approval characterized comparability Control COVID-19 COVID-19 pandemic COVID-19 situation Digital Digitalization genetically modified organisms global public health globe harmonization Health authority Health crisis heterogeneity highlight lack Medicine Medicines organism pandemic Part patients Population Regulatory Regulatory convergence Reliance Risk-based Science-based shown situation stability Streamline to be done trade-off trade-offs Vaccine variants Volume [DOI] 10.1016/j.vaccine.2021.11.098 PMC 바로가기 [Article Type] Review
The Comparability of Anti-Spike SARS-CoV-2 Antibody Tests is Time-Dependent: a Prospective Observational StudyAnti-Spike SARS-CoV-2 항체 검사의 비교 가능성은 시간에 따라 달라집니다: 전향적 관찰 연구Observational Study Published on 2022-02-232022-09-12 Journal: Microbiology Spectrum [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] Abbott agreement antibody Antibody assays antibody levels Antibody test antibody tests AZD1222 binding antibody Blood blood collection booster changed clinical setting clinical settings clinician comparability correlation dependent on evaluated first dose greater homologous Initially International international standard Neutralization assay observational study participant Prospective prospective observational study provided quantified Quantitative Roche SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 antibody test SARS-CoV-2 antibody tests second dose serology significantly Standardization Test the timing time-dependency vaccination Withdrawal [DOI] 10.1128/spectrum.01402-21 PMC 바로가기 [Article Type] Observational Study
Studying the post-COVID-19 condition: research challenges, strategies, and importance of Core Outcome Set developmentOpinion Published on 2022-02-042022-10-28 Journal: BMC Medicine [Category] COVID-19, COVID19(2023년), Fulltext, MERS, SARS, [키워드] acute infection Clinical practice cognitive comparability core Core outcome set COVID COVID-19 COVID-19 sequalae defined develop diagnosed disease dysfunction Evidence fatigue Frame geographical locations Health healthcare professionals Long COVID neurological outcome outcome measure outcomes PASC Patient patients people with COVID-19 populations Post-acute sequelae of SARS-CoV-2 infection post-COVID-19 condition Research researchers SARS-COV-2 infection Shortness of breath Symptom while [DOI] 10.1186/s12916-021-02222-y PMC 바로가기 [Article Type] Opinion
Rapid cGMP manufacturing of COVID-19 monoclonal antibody using stable CHO cell pools안정적인 CHO 세포 풀을 사용하여 COVID-19 단일 클론 항체의 신속한 cGMP 제조Article Published on 2022-02-012022-09-11 Journal: Biotechnology and bioengineering [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] accelerated activities acute respiratory syndrome acute respiratory syndrome coronavirus approach Cell cell bank Cell culture cGMP cGMP manufacturing CHO cell CHO pools clinical trial clone comparability coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 Critical demonstrated Final generate host cell material monoclonal antibodies monoclonal antibody pandemic performed Phase 1 Phase 1 clinical trial Proteins provided Rapid respiratory subsequent supply Testing timeline transposase [DOI] 10.1002/bit.27995 PMC 바로가기 [Article Type] Article
COVID-19 data are messy: analytic methods for rigorous impact analyses with imperfect dataCommentary Published on 2022-01-062022-11-01 Journal: Globalization and Health [Category] COVID-19, SARS, [키워드] addressed Analysis approach comparability Completeness COVID-19 COVID-19 pandemic COVID-19 research Effectiveness effort epidemiologist explicit Government help identify Impact analysis Interrupted time-series analysis Intervention longitudinal study Non-pharmaceutical interventions observational studies outcome problem recommendation Research researcher Result sensitivity analysis Study design Surveillance biases surveillance data threat Validity variable variables [DOI] 10.1186/s12992-021-00795-0 PMC 바로가기 [Article Type] Commentary
Quality comparability assessment of a SARS-CoV-2-neutralizing antibody across transient, mini-pool-derived and single-clone CHO cells일시적인 미니 풀 유래 및 단일 클론 CHO 세포 전반에 걸친 SARS-CoV-2 중화 항체의 품질 동등성 평가Comparative Study Published on 2022-01-012022-09-12 Journal: mAbs [Category] SARS, 진단, [키워드] accelerate acute respiratory syndrome adopted Cell cell line Chemistry Chinese hamster CHO cell clinical trial comparability comparable conducted Control coronavirus Degradation immunological functions indicated measure mini-pool monoclonal antibody Neutralizing neutralizing antibody patients Phase 1 profiles public health crisis Quality Research SARS-CoV-2 SARS-CoV-2-neutralizing antibody Spike protein stress condition structures Support the disease the SARS-CoV-2 therapeutic transient. triggered Variation [DOI] 10.1080/19420862.2021.2005507 PMC 바로가기 [Article Type] Comparative Study
Harmonized D-dimer levels upon admission for prognosis of COVID-19 severity: Results from a Spanish multicenter registry (BIOCOVID-Spain study)COVID-19 심각도의 예후를 위해 입원 시 조화된 D-dimer 수준: 스페인 다기관 등록의 결과(BIOCOVID-스페인 연구)Multicenter Study Published on 2022-01-012022-09-11 Journal: Journal of Thrombosis and Thrombolysis [Category] 바이오마커, [키워드] adjusted hazard ratio Admission an area Analysis approach assays association characteristic Clinical practice Coagulopathy comparability COVID-19 COVID-19 patients Cox regression analysis cut-off value D-dimer D-dimer level D-dimer levels death defined dimer Endpoint FEU greater harmonization hospital mortality rate in-hospital mortality in-hospital mortality rate independent Mortality mortality rate multicenter patients Prognosis prognostic receiver operating characteristic regression line reported Result Retrospective multicenter study risk severity Spanish study population test results transformation translate was performed [DOI] 10.1007/s11239-021-02527-y PMC 바로가기 [Article Type] Multicenter Study